This Review describes recent advances in our understanding of tumour-associated myeloid cells in tumour progression and responses to therapy, discussing possible avenues to manipulate these cells in the tumour microenvironment.
- Camilla Engblom
- Christina Pfirschke
- Mikael J. Pittet
